A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisHoward Trachtman, Flavio Vincenti, David Jayne et al.|Kidney International|2011Cited by 258
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosisEva Königshausen, Lorenz Sellin|Scientific Reports|2016Cited by 33
Modulation of renal tubular cell function by RGS3W Grüning, Gerd Walz, Thierry Arnould et al.|American Journal of Physiology-Renal Physiology|1999Cited by 17
A molecular mechanism for angiotensin <scp>II</scp> receptor blocker‐mediated slit membrane protection: Angiotensin <scp>II</scp> increases nephrin endocytosis via <scp>AT1</scp> ‐receptor‐dependent <scp>ERK</scp> 1/2 activationEva Königshausen, Lorenz Sellin|The FASEB Journal|2024Cited by 1